Novo CEO pressed by Senate to chop rates of obesity, diabetes medicine CEO Lars Fruergaard Jørgensen told lawmakers the organization would consider new talks with insurers concerning the list price ranges of Wegovy and copyright should they pledge to help keep the medicines on their own formularies. Don't miss tomorrow's https://buschlightpeachnutritionf98631.prublogger.com/30078644/the-single-best-strategy-to-use-for-healthcare-news